News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
326,876 Results
Type
Article (26892)
Company Profile (149)
Press Release (299835)
Section
Business (92672)
Career Advice (1320)
Deals (14398)
Drug Delivery (81)
Drug Development (38701)
Employer Resources (152)
FDA (8238)
Job Trends (8655)
News (155697)
Policy (13747)
Tag
Academia (1991)
Alliances (25501)
Alzheimer's disease (828)
Approvals (8242)
Artificial intelligence (144)
Bankruptcy (99)
Best Places to Work (7418)
Biotechnology (92)
Breast cancer (129)
Cancer (928)
Cardiovascular disease (88)
Career advice (1159)
Cell therapy (218)
Clinical research (31072)
Collaboration (444)
Compensation (135)
COVID-19 (1406)
C-suite (111)
Cystic fibrosis (84)
Data (1043)
Diabetes (128)
Diagnostics (3368)
Earnings (26540)
Employer resources (133)
Events (49027)
Executive appointments (400)
FDA (8842)
Funding (401)
Gene therapy (176)
GLP-1 (381)
Government (2335)
Healthcare (10022)
Infectious disease (1475)
Inflammatory bowel disease (96)
Interviews (197)
IPO (6461)
Job creations (1598)
Job search strategy (1014)
Layoffs (185)
Legal (2236)
Lung cancer (133)
Manufacturing (149)
Medical device (6483)
Medtech (6487)
Mergers & acquisitions (8210)
Metabolic disorders (319)
Neuroscience (1100)
NextGen: Class of 2025 (3744)
Non-profit (3464)
Northern California (1201)
Obesity (173)
Opinion (132)
People (33568)
Phase I (8973)
Phase II (13429)
Phase III (11492)
Pipeline (387)
Postmarket research (1246)
Preclinical (3931)
Radiopharmaceuticals (123)
Rare diseases (240)
Real estate (3225)
Regulatory (10148)
Research institute (1739)
Resumes & cover letters (169)
Southern California (973)
Startups (2378)
United States (10446)
Vaccines (300)
Weight loss (116)
Date
Today (5)
Last 7 days (343)
Last 30 days (1596)
Last 365 days (20027)
2025 (2707)
2024 (20387)
2023 (22766)
2022 (28074)
2021 (31157)
2020 (28800)
2019 (25558)
2018 (19024)
2017 (16616)
2016 (16122)
2015 (17745)
2014 (12883)
2013 (10439)
2012 (10969)
2011 (11340)
2010 (10218)
Location
Africa (489)
Arizona (97)
Asia (18863)
Australia (3398)
California (2674)
Canada (869)
China (194)
Colorado (109)
Connecticut (146)
Delaware (81)
Europe (46623)
Florida (419)
Georgia (110)
Illinois (241)
Indiana (212)
Japan (100)
Maryland (370)
Massachusetts (2060)
Michigan (130)
Minnesota (180)
New Jersey (867)
New York (821)
North Carolina (539)
Northern California (1201)
Ohio (112)
Pennsylvania (561)
South America (634)
Southern California (973)
Texas (355)
Washington State (193)
326,876 Results for "wave life sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
February 6, 2025
·
5 min read
Press Releases
Wave Life Sciences to Present at Upcoming Investor Conferences
November 26, 2024
·
1 min read
Press Releases
Wave Life Sciences to Present at Jefferies London Healthcare Conference
November 15, 2024
·
1 min read
Press Releases
Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation
January 14, 2025
·
13 min read
Press Releases
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 16, 2024
·
1 min read
Huntington’s disease
Takeda Walks Away From Wave Huntington’s Partnership After Sinking $260M in Collaboration
Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on Wave’s WVE-003 clinical-stage Huntington’s disease program—a potential $5 billion commercial opportunity, according to the biotech.
October 16, 2024
·
3 min read
·
Tristan Manalac
Press Releases
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity
December 23, 2024
·
5 min read
Venture capitalists
Blackstone Launches New $5B+ Fund for Life Sciences
Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.
January 31, 2025
·
2 min read
·
Tristan Manalac
Business
Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
Wave Life Sciences Ltd., a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, announced the appointment of Erik Ingelsson, MD, PhD, as Chief Scientific Officer.
May 9, 2024
·
6 min read
Genetown
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
Wave Life Sciences Ltd. provided an update on its best-in-class small interfering RNA and RNA editing platform capabilities.
April 23, 2024
·
6 min read
1 of 32,688
Next
